🇮🇳IN
Sign In
KR

KREBSBIO

NSE

Krebs Biochemicals and Industries Limited

₹57.93

-1.22(-2.06%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

KREBSBIO financial summary

For Mar 2026, Krebs Biochemicals and Industries Limited reported revenue of ₹24 crore, which fell 44.2% from the previous year. Net profit was -₹17 crore, on an operating margin of -23%. Earnings per share came in at -₹7.85. Annual results are available for 14 financial years, from Jun 2013 to Mar 2026.

Revenue₹24 crore
Net profit-₹17 crore
Operating margin-23%
EPS-₹7.85

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer